{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:30:05Z","timestamp":1768537805488,"version":"3.49.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>While the global pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is still ongoing and new virus variants are emerging, there is a universal need for vaccines to protect individuals from severe complications and ideally control the pandemic by enabling herd immunity. Several vaccines against SARS-CoV-2 have been approved and are widely used to stem the recurring waves of coronavirus disease 2019 (COVID-19). Post-marketing surveillance is essential to record even rare safety issues related to these new vaccines. Among these issues, several autoimmune phenomena have been recorded in temporal association with and feasibly triggered by a vaccination. Acquired haemophilia A (AHA) is a rare condition characterized by new-onset haemorrhagic diathesis caused by an inhibitor of blood clotting factor VIII (FVIII), often in the elderly and most commonly associated with autoimmune or malignant disease. There have been a small number of AHA cases triggered by vaccinations, including those against SARS-CoV-2. We report the first case of AHA in temporal association with an mRNA-1273 booster vaccination. The diagnosis was made promptly, and the patient received appropriate care including immunosuppression using glucocorticoids, cyclophosphamide (CYC) and rituximab (RTX). The haemorrhage ceased after escalation of treatment, and the patient is recovering. Concurrent malignancy was initially ruled out using a wide scope of diagnostic tests, but pleomorphic dermal sarcoma (PDS) of the forehead occurred after initiation of specific AHA immunosuppressive treatment. Since large vaccination programs are ongoing worldwide and potential adverse events during post-marketing surveillance have been reported following vaccination against SARS-CoV-2, this case illustrates challenges in rare events occurring in association with SARS-CoV-2 vaccination and to proof a causal relationship. Therefore, there is an urgent need for reporting any events in association with SARS-CoV-2 vaccination, but also a crucial discussion about possible concurrent triggers and follow-up information about individual patients.<\/jats:p>","DOI":"10.3389\/fimmu.2022.868133","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T06:05:21Z","timestamp":1649657121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Marlene","family":"Pl\u00fc\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mitteldorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph Johannes","family":"Szuszies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/vaccines9050433","article-title":"An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times","volume":"9","author":"Garcia-Montero","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A Guide to Vaccinology: From Basic Principles to New Developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired Hemophilia A: A Concise Review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired Hemophilia A in the United Kingdom: A 2-Year National Surveillance Study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650169","article-title":"A Survey of 215 Non-Hemophilic Patients With Inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic Factors for Remission of and Survival in Acquired Hemophilia A (AHA): Results From the GTH-AH 01\/2010 Study","volume":"125","author":"Tiede","year":"2015","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771","article-title":"International Recommendations on the Diagnosis and Treatment of Acquired Hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0852-z","article-title":"Acquired Factor VIII Haemophilia Following Influenza Vaccination","volume":"66","author":"Moulis","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2516.2011.02493.x","article-title":"A Case of Acquired Haemophilia Following H1N1 Vaccination","volume":"17","author":"Pirrotta","year":"2011","journal-title":"Haemophilia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16254","article-title":"De Novo Acquired Hemophilia as an Immune Dysregulation Phenomenon Following SARS-CoV-2 Infection","volume":"61","author":"Olsen","year":"2021","journal-title":"Transfusion"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242884","article-title":"Severe Acquired Haemophilia Associated With Asymptomatic SARS-CoV-2 Infection","volume":"14","author":"Wang","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25865","article-title":"The First Case of Acquired Hemophilia A Associated With SARS-CoV-2 Infection","volume":"95","author":"Franchini","year":"2020","journal-title":"Am J Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15291","article-title":"A Case Report of Acquired Hemophilia Following COVID-19 Vaccine","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14442","article-title":"A Case of Acquired Haemophilia A in a 70-Year-Old Post COVID-19 Vaccine","volume":"28","author":"Lemoine","year":"2022","journal-title":"Haemophilia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1055\/a-1579-5396","article-title":"Autoimmunity After Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A","volume":"121","author":"Farley","year":"2021","journal-title":"Thromb Haemost"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.01.017","article-title":"Four Cases of Acquired Hemophilia A Following Immunization With mRNA BNT162b2 SARS-CoV-2 Vaccine","volume":"211","author":"Leone","year":"2022","journal-title":"Thromb Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14740\/jmc3827","article-title":"Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication","volume":"13","author":"Soliman","year":"2022","journal-title":"J Med Cases"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246922","article-title":"Case of Acquired Haemophilia A in Southeast Asia Following COVID-19 Vaccine","volume":"15","author":"Ai Vuen","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e21909","DOI":"10.7759\/cureus.21909","article-title":"Acquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review","volume":"14","author":"Al Hennawi","year":"2022","journal-title":"Cureus"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308101436","article-title":"Testing for Lupus Anticoagulants: All That a Clinician Should Know","volume":"18","author":"Tripodi","year":"2009","journal-title":"Lupus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649988","article-title":"Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants. On Behalf of the Subcommittee on Lupus Anticoagulants\/Antiphospholipid Antibodies of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2621","DOI":"10.7759\/cureus.2621","article-title":"Acquired Hemophilia Secondary to Soft-Tissue Sarcoma: Case Report From a Latin American Hospital and Literature Review","volume":"10","author":"Casadiego-Pena","year":"2018","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000314274","article-title":"Acquired Haemophilia A and Kaposi\u2019s Sarcoma in an HIV-Negative, HHV-8-Positive Patient: A Discussion of Mechanism and Aetiology","volume":"124","author":"Cashin","year":"2010","journal-title":"Acta Haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14700","article-title":"S1-Guideline Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS)","volume":"20","author":"Helbig","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15421","article-title":"The Statistical Risk of Diagnosing Coincidental Acquired Hemophilia A Following Anti-SARS-CoV-2 Vaccination","volume":"19","author":"Cittone","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00309-X","article-title":"Cutaneous Vasculitis Following COVID-19 Vaccination","volume":"3","author":"Cavalli","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/art.41910","article-title":"Leukocytoclastic Vasculitis After Vaccination With a SARS-CoV-2 Vaccine","volume":"73","author":"Erler","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3201\/eid2712.211634","article-title":"Guillain-Barre Syndrome Associated With COVID-19 Vaccination","volume":"27","author":"Shao","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00416-6","article-title":"Guillain-Barre Syndrome After Vaccination Against COVID-19","volume":"21","author":"Chun","year":"2021","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and Autoimmune Disease: What Is the Evidence","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.868133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T18:06:37Z","timestamp":1649700397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.868133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.868133"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.868133","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"article-number":"868133"}}